BP1041

舒林酸

British Pharmacopoeia (BP) Reference Standard

• 别名: (Z)-5-氟-2-甲基-1-[4-(甲亚硫酰苯基)亚甲基]-1H-茚-3-醋酸
• 经验公式（希尔记法）: C₂₀H₁₇FO₃S
• CAS号: 38194-50-2
• 分子量: 356.41
• MDL號碼: MFCD00599589
• 分類程式碼代碼: 41116107
• NACRES: NA.24

属性

• 等級: pharmaceutical primary standard
• API 家族: sulindac
• 形狀: solid
• 儲存期限: limited shelf life, expiry date on the label
• 製造商／商標名: BP
• 應用: pharmaceutical; pharmaceutical small molecule
• 格式: neat
• 儲存溫度: 2-8°C
• SMILES 字串: CC1=C(CC(O)=O)c2cc(F)ccc2\C1=C/c3ccc(cc3)S(C)=O
• InChI: 1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-
• InChI 密鑰: MLKXDPUZXIRXEP-MFOYZWKCSA-N
• 基因資訊: human ... PTGS1(5742) , PTGS2(5743)

说明

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Sulindac BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Sulindac Tablets

生化／生理作用

非甾体抗炎药；COX-1 的选择性抑制剂。

包裝

Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia.

其他說明

Sales restrictions may apply.

安全信息

• 象形圖: GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H301,H317,H334,H361
• 防範說明: P201 - P261 - P280 - P301 + P310 + P330 - P304 + P340 - P308 + P313
• 危險分類: Acute Tox. 3 Oral - Repr. 2 - Resp. Sens. 1 - Skin Sens. 1
• 儲存類別代碼: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable